Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD

被引：186

作者：

Andrews, Katrina A. ^{[1
,2
,3
,4
]}

Ascher, David B. ^{[5
,6
]}

Pires, Douglas Eduardo Valente ^{[5
,7
]}

Barnes, Daniel R. ^{[8
]}

Vialard, Lindsey ^{[9
]}

Casey, Ruth T. ^{[1
,2
,3
,4
]}

Bradshaw, Nicola ^{[10
]}

Adlard, Julian ^{[11
]}

Aylwin, Simon ^{[12
]}

Brennan, Paul ^{[13
]}

Brewer, Carole ^{[14
]}

Cole, Trevor ^{[9
]}

Cook, Jackie A. ^{[15
]}

Davidson, Rosemarie ^{[10
]}

Donaldson, Alan ^{[16
]}

Fryer, Alan ^{[17
]}

Greenhalgh, Lynn ^{[17
]}

Hodgson, Shirley V. ^{[18
]}

Irving, Richard ^{[19
]}

Lalloo, Fiona ^{[20
]}

McConachie, Michelle ^{[21
]}

McConnell, Vivienne P. M. ^{[22
]}

Morrison, Patrick J. ^{[22
]}

Murday, Victoria ^{[10
]}

Park, Soo-Mi ^{[23
]}

Simpson, Helen L. ^{[24
]}

Snape, Katie ^{[18
]}

Stewart, Susan ^{[9
]}

Tomkins, Susan E. ^{[16
]}

Wallis, Yvonne ^{[9
]}

Izatt, Louise ^{[25
]}

Goudie, David ^{[21
]}

Lindsay, Robert S. ^{[26
]}

Perry, Colin G. ^{[26
]}

Woodward, Emma R.

Antoniou, Antonis C. ^{[8
]}

Maher, Eamonn R. ^{[1
,2
,3
,4
,24
]}

机构：

[1] Univ Cambridge, Dept Med Genet, Cambridge CB2 0QQ, England

[2] NIHR Cambridge Biomed Res Ctr, Cambridge, England

[3] Canc Res UK Cambridge Canc Ctr, Cambridge, England

[4] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England

[5] Univ Cambridge, Dept Biochem, Cambridge, England

[6] Univ Melbourne, Inst Bio21, Dept Biochem & Mol Biol, Melbourne, Vic, Australia

[7] Fundacao Oswaldo Cruz, Inst Rene Rachou, Belo Horizonte, MG, Brazil

[8] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England

[9] Birmingham Womens Hosp, West Midlands Reg Genet Serv, Birmingham, W Midlands, England

[10] Queen Elizabeth Univ Hosp, Dept Clin Genet, Glasgow, Lanark, Scotland

[11] St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England

[12] Kings Coll Hosp London, Dept Endocrinol, London, England

[13] Newcastle upon Tyne Hosp NHS Fdn Trust, Northern Genet Serv, Newcastle Upon Tyne, Tyne & Wear, England

[14] Royal Devon & Exeter Hosp, Peninsula Clin Genet Serv, Exeter, Devon, England

[15] Sheffield Childrens Hosp, Dept Clin Genet, Sheffield, S Yorkshire, England

[16] St Michaels Hosp, Dept Clin Genet, Bristol, Avon, England

[17] Liverpool Womens NHS Fdn Trust, Dept Clin Genet, Liverpool, Merseyside, England

[18] St Georges Univ London, Dept Med Genet, London, England

[19] Queen Elizabeth Hosp, Queen Elizabeth Med Ctr, Birmingham, W Midlands, England

[20] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester Ctr Genom Med, Manchester, Lancs, England

[21] Ninewells Hosp & Med Sch, East Scotland Reg Genet Serv, Dundee, Scotland

[22] Belfast Hlth & Social Care Trust, Belfast City Hosp, Northern Ireland Reg Genet Serv, Belfast, Antrim, North Ireland

[23] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Treatment Ctr, Dept Clin Genet, Cambridge, England

[24] Cambridge Univ Hosp NHS Fdn Trust, Inst Metab Sci, Wolfson Diabet & Endocrine Clin, Cambridge, England

[25] Guys Hosp, Dept Clin Genet, London, England

[26] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland

来源：

JOURNAL OF MEDICAL GENETICS | 2018年 / 55卷 / 06期

基金：

英国医学研究理事会; 欧洲研究理事会; 澳大利亚国家健康与医学研究理事会;

关键词：

COMPLEX-II; MUTATION CARRIERS; MATERNAL TRANSMISSION; NECK PARAGANGLIOMA; PROTEIN STABILITY; PHEOCHROMOCYTOMA; PENETRANCE; SUSCEPTIBILITY; GENETICS; DELETION;

D O I：

10.1136/jmedgenet-2017-105127

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Background Germline pathogenic variants in SDHB/SDHC/SDHD are the most frequent causes of inherited phaeochromocytomas/paragangliomas. Insufficient information regarding penetrance and phenotypic variability hinders optimum management of mutation carriers. We estimate penetrance for symptomatic tumours and elucidate genotype-phenotype correlations in a large cohort of SDHB/SDHC/SDHD mutation carriers. Methods A retrospective survey of 1832 individuals referred for genetic testing due to a personal or family history of phaeochromocytoma/paraganglioma. 876 patients (401 previously reported) had a germline mutation in SDHB/SDHC/SDHD (n=673/43/160). Tumour risks were correlated with in silico structural prediction analyses. Results Tumour risks analysis provided novel penetrance estimates and genotype-phenotype correlations. In addition to tumour type susceptibility differences for individual genes, we confirmed that the SDHD: p.Pro81Leu mutation has a distinct phenotype and identified increased age-related tumour risks with highly destabilising SDHB missense mutations. By Kaplan-Meier analysis, the penetrance (cumulative risk of clinically apparent tumours) in SDHB and (paternally inherited) SDHD mutation-positive non-probands (n=371/67 with detailed clinical information) by age 60 years was 21.8% (95% CI 15.2% to 27.9%) and 43.2% (95% CI 25.4% to 56.7%), respectively. Risk of malignant disease at age 60 years in non-proband SDHB mutation carriers was 4.2%(95% CI 1.1% to 7.2%). With retrospective cohort analysis to adjust for ascertainment, cumulative tumour risks for SDHB mutation carriers at ages 60 years and 80 years were 23.9% (95% CI 20.9% to 27.4%) and 30.6% (95% CI 26.8% to 34.7%). Conclusions Overall risks of clinically apparent tumours for SDHB mutation carriers are substantially lower than initially estimated and will improve counselling of affected families. Specific genotype-tumour risk associations provides a basis for novel investigative strategies into succinate dehydrogenase-related mechanisms of tumourigenesis and the development of personalised management for SDHB/SDHC/SDHD mutation carriers.

引用

页码：384 / 394

页数：11

共 61 条

[51] Germline SDHB mutations and familial renal cell carcinoma [J].

Ricketts, Christopher ;

Woodward, Emma R. ;

Killick, Pip ;

Morris, Mark R. ;

Astuti, Dewi ;

Latif, Farida ;

Maher, Eamonn R. .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (17) :1260-1262

[52] Tumor Risks and Genotype-Phenotype-Proteotype Analysis in 358 Patients With Germline Mutations in SDHB and SDHD [J].

Ricketts, Christopher J. ;

Forman, Julia R. ;

Rattenberry, Eleanor ;

Bradshaw, Nicola ;

Lalloo, Fiona ;

Izatt, Louise ;

Cole, Trevor R. ;

Armstrong, Ruth ;

Kumar, V. K. Ajith ;

Morrison, Patrick J. ;

Atkinson, A. Brew ;

Douglas, Fiona ;

Ball, Steve G. ;

Cook, Jackie ;

Srirangalingam, Umasuthan ;

Killick, Pip ;

Kirby, Gail ;

Aylwin, Simon ;

Woodward, Emma R. ;

Evans, D. Gareth R. ;

Hodgson, Shirley V. ;

Murday, Vicky ;

Chew, Shern L. ;

Connell, John M. ;

Blunde, Tom L. ;

MacDonald, Fiona ;

Maher, Eamonn R. .

HUMAN MUTATION, 2010, 31 (01) :41-51

[53] The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers [J].

Rijken, J. A. ;

Niemeijer, N. D. ;

Jonker, M. A. ;

Eijkelenkamp, K. ;

Jansen, J. C. ;

van Berkel, A. ;

Timmers, H. J. L. M. ;

Kunst, H. P. M. ;

Bisschop, P. H. L. T. ;

Kerstens, M. N. ;

Dreijerink, K. M. A. ;

van Dooren, M. F. ;

van der Horst-Schrivers, A. N. A. ;

Hes, F. J. ;

Leemans, C. R. ;

Corssmit, E. P. M. ;

Hensen, E. F. .

CLINICAL GENETICS, 2018, 93 (01) :60-66

[54] Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletion [J].

Rijken, J. A. ;

Niemeijer, N. D. ;

Corssmit, E. P. M. ;

Jonker, M. A. ;

Leemans, C. R. ;

Menko, F. H. ;

Hensen, E. F. .

CLINICAL GENETICS, 2016, 89 (01) :128-132

[55] Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene [J].

Schiavi, F ;

Boedeker, CC ;

Bausch, B ;

Peçzkowska, M ;

Gomez, CF ;

Strassburg, T ;

Pawlu, C ;

Buchta, M ;

Salzmann, M ;

Hoffmann, MM ;

Berlis, A ;

Brink, I ;

Cybulla, M ;

Muresan, M ;

Walter, MA ;

Forrer, F ;

Välimäki, M ;

Kawecki, A ;

Szutkowski, Z ;

Schipper, J ;

Walz, MK ;

Pigny, P ;

Banters, C ;

Willet-Brozick, JE ;

Baysal, BE ;

Januszewicz, A ;

Eng, C ;

Opocher, G ;

Neumann, HPH .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (16) :2057-2063

[56] Are We Overestimating the Penetrance of Mutations in SDHB? [J].

Schiavi, Francesca ;

Milne, Roger L. ;

Anda, Emma ;

Blay, Pilar ;

Castellano, Maurizio ;

Opocher, Giuseppe ;

Robledo, Mercedes ;

Cascon, Alberto .

HUMAN MUTATION, 2010, 31 (06) :761-762

[57] Penetrance and clinical consequences of a gross SDHB deletion in a large family [J].

Solis, D. C. ;

Burnichon, N. ;

Timmers, H. J. L. M. ;

Raygada, M. J. ;

Kozupa, A. ;

Merino, M. J. ;

Makey, D. ;

Adams, K. T. ;

Venisse, A. ;

Gimenez-Roqueplo, A-P ;

Pacak, K. .

CLINICAL GENETICS, 2009, 75 (04) :354-363

[58] Crystal structure of mitochondrial respiratory membrane protein complex II [J].

Sun, F ;

Huo, X ;

Zhai, YJ ;

Wang, AJ ;

Xu, JX ;

Su, D ;

Bartlam, M ;

Rao, ZH .

CELL, 2005, 121 (07) :1043-1057

[59] Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas [J].

Toledo, Rodrigo A. ;

Burnichon, Nelly ;

Cascon, Alberto ;

Benn, Diana E. ;

Bayley, Jean-Pierre ;

Welander, Jenny ;

Tops, Carli M. ;

Firth, Helen ;

Dwight, Trish ;

Ercolino, Tonino ;

Mannelli, Massimo ;

Opocher, Giuseppe ;

Clifton-Bligh, Roderick ;

Gimm, Oliver ;

Maher, Eamonn R. ;

Robledo, Mercedes ;

Gimenez-Roqueplo, Anne-Paule ;

Dahia, Patricia L. M. .

NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (04) :233-247

[60] Outcomes of annual surveillance imaging in an adult and paediatric cohort of succinate dehydrogenase B mutation carriers [J].

Tufton, Nicola ;

Shapiro, Lucy ;

Srirangalingam, Umasuthan ;

Richards, Polly ;

Sahdev, Anju ;

Kumar, Ajith V. ;

McAndrew, Lorraine ;

Martin, Lee ;

Berney, Daniel ;

Monson, John ;

Chew, Shern L. ;

Waterhouse, Mona ;

Druce, Maralyn ;

Korbonits, Marta ;

Metcalfe, Karl ;

Drake, William M. ;

Storr, Helen L. ;

Akker, Scott A. .

CLINICAL ENDOCRINOLOGY, 2017, 86 (02) :286-296

← 1 2 3 4 5 6 7 →